Karl Doerner

Karl Doerner has extensive work experience in the biotechnology industry. Karl is currently working as a Senior Manager Nonclinical Operations at Tenaya Therapeutics since January 2022. Prior to that, they worked at Nurix Therapeutics for seven years, holding the role of Scientist from July 2015 to January 2022. Karl also had a brief stint as a Scientist at Rinat - Pfizer from October 2008 to July 2015. Before joining Rinat - Pfizer, Karl worked as a Senior Research Associate at FibroGen from October 2007 to October 2008. Karl started their career at Genentech, where they worked as a Research Associate II from February 2004 to September 2007. Karl also gained research experience as a Research Associate at Sugen Inc from May 2002 to July 2003. Karl began their professional journey as a Research Technician at Brandeis University - HHMI Rosbash lab from June 2001 to May 2002. Karl's early experience includes working as a Lab Tech at UMass Boston - Gindhart Lab from 1999 to 2001.

Karl Doerner completed their education in a chronological manner. Karl attended the University of Oregon from 1993 to 1997, where they pursued studies in Music and Chemistry, although they did not obtain a degree. Subsequently, from 1999 to 2002, Karl studied at UMass Boston, earning a BS/MS in Biochemistry.